Migita Hideyuki, Morser John
Department of Pharmacology, Berlex Biosciences, Richmond, CA 94806, USA.
Arterioscler Thromb Vasc Biol. 2005 Apr;25(4):710-6. doi: 10.1161/01.ATV.0000156482.76228.d1. Epub 2005 Jan 20.
15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2), a natural ligand of the peroxisome proliferator-activated receptor-gamma (PPARgamma), has been shown to inhibit proinflammatory gene expression, but the signaling mechanisms involved remain unclear. Because retinoic acid receptor-related orphan receptor-alpha (RORalpha) has been reported to suppress tumor necrosis factor-alpha (TNF-alpha)-induced expression of proinflammatory genes, we hypothesized that 15d-PGJ2 may induce RORalpha expression resulting in inhibition of proinflammatory gene expression.
We demonstrate that 15d-PGJ2 induced RORalpha1 and RORalpha4 expression and inhibited TNF-alpha-induced vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1) expression in human umbilical vein endothelial cells (HUVECs). In contrast, the synthetic PPARgamma ligand pioglitazone weakly induced RORalpha4 expression but did not affect RORalpha1 expression or TNF-alpha-induced gene expression. Biphenol A diglycidyl ether, a PPARgamma antagonist, did not block the effect of 15d-PGJ2 on RORalpha expression. Adenovirus-mediated overexpression of RORalpha1 inhibited TNF-alpha-induced VCAM-1 and ICAM-1 expression, and overexpression of a mutant form of RORalpha1 (RORalpha1Delta), which inhibited transcriptional activity of RORalpha1 and RORalpha4, attenuated its inhibition. Furthermore, we found that RORalpha1Delta attenuated the inhibitory actions of 15d-PGJ2 on TNF-alpha-induced VCAM-1 and ICAM-1 expression.
These results suggest that 15d-PGJ2 inhibits TNF-alpha-induced expression of proinflammatory genes mediated in part via induction of RORalpha in HUVECs. This mechanism provides a novel insight into PPARgamma-independent actions of 15d-PGJ2.
15-脱氧-Δ12,14-前列腺素J2(15d-PGJ2)是过氧化物酶体增殖物激活受体γ(PPARγ)的天然配体,已被证明可抑制促炎基因表达,但其涉及的信号传导机制仍不清楚。由于据报道维甲酸受体相关孤儿受体α(RORα)可抑制肿瘤坏死因子α(TNF-α)诱导的促炎基因表达,我们推测15d-PGJ2可能诱导RORα表达,从而抑制促炎基因表达。
我们证明15d-PGJ2可诱导人脐静脉内皮细胞(HUVECs)中RORα1和RORα4表达,并抑制TNF-α诱导的血管细胞黏附分子-1(VCAM-1)和细胞间黏附分子-1(ICAM-1)表达。相比之下,合成的PPARγ配体吡格列酮微弱诱导RORα4表达,但不影响RORα1表达或TNF-α诱导的基因表达。PPARγ拮抗剂双酚A二缩水甘油醚不阻断15d-PGJ2对RORα表达的作用。腺病毒介导的RORα1过表达抑制TNF-α诱导的VCAM-1和ICAM-1表达,而抑制RORα1和RORα4转录活性的RORα1突变体形式(RORα1Delta)的过表达减弱了其抑制作用。此外,我们发现RORα1Delta减弱了15d-PGJ2对TNF-α诱导的VCAM-1和ICAM-1表达的抑制作用。
这些结果表明,15d-PGJ2在HUVECs中部分通过诱导RORα抑制TNF-α诱导的促炎基因表达。这一机制为15d-PGJ2不依赖PPARγ的作用提供了新的见解。